Cardio-oncology decision-making during trastuzumab-related cardiac dysfunction in high-risk HER2-positive breast cancer: a permissive cardiotoxicity approach

28 August 2026 (10:57 - 11:09)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology beyond cardiotoxicity Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology